Form 4: MariMed Inc. Insider Trading: Jon R. Levine Transactions

MariMed Inc. reports insider transactions by President and CEO Jon R. Levine, involving restricted stock units and common stock.

Summary

• Jon R. Levine, President and CEO of MariMed Inc., reported transactions on April 2, 2026.
• He acquired 11,518 shares of common stock upon the conversion of Restricted Stock Units (RSUs) with a transaction price of $0.
• Additionally, 3,992 shares were disposed of, reflecting shares withheld by the Issuer to satisfy tax obligations related to RSU vesting, at a price of $0.0691 per share.
• Following these transactions, Levine beneficially owns 21,162,966 shares of common stock directly.
• He also holds 6,684,640 shares indirectly through the Jon Levine Family Trust.
• Levine holds 23,034 RSUs, with remaining vesting dates on October 2, 2026, and April 2, 2027.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it details routine insider transactions related to RSU vesting and tax obligations, without indicating significant positive or negative shifts in executive confidence or shareholding strategy.

Positives

• Acquisition of 11,518 shares of common stock through RSU conversion indicates continued equity ownership by a key executive.
• The retention of a significant number of shares (21,162,966 directly and 6,684,640 indirectly) suggests confidence in the company's future.

Negatives

• Disposal of 3,992 shares to cover tax withholding obligations, while standard, represents a reduction in direct share count.

Risks

• The disposal of shares for tax withholding, while routine, could be perceived negatively if it were a larger proportion of holdings.
• Future vesting of RSUs on October 2, 2026, and April 2, 2027, could lead to further share disposals for tax purposes.

Future Outlook

The filing indicates that remaining RSUs are scheduled to vest in two equal installments on October 2, 2026, and April 2, 2027, which may result in further share transactions for tax withholding.

Industry Context

StockSavvy.ai notes that insider transactions, particularly Form 4 filings, are crucial for understanding executive sentiment and potential shifts in beneficial ownership within the cannabis industry, which is subject to evolving regulations and market dynamics.

Stakeholder Impact

• Shareholders: The transactions represent standard executive compensation and tax management, with no immediate indication of a change in overall beneficial ownership strategy.
• Employees: The RSU vesting process is a standard component of executive compensation.
• Management: Jon R. Levine continues to hold a substantial direct and indirect stake in the company.

Next Steps

• Monitoring future RSU vesting dates on October 2, 2026, and April 2, 2027.
• Observing any further transactions reported by Jon R. Levine.

Key Dates

Keywords

MariMed Inc., MRMD, Form 4, Insider Trading, Jon R. Levine, Restricted Stock Units, RSU Vesting, Beneficial Ownership, SEC Filing, Executive Compensation